DXR insider buying and SEC filings, explained
Daxor Corp. · CIK 27367
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Apr 8, 2026 | Purchase (code P) | Michael Richard Feldschuh (CEO and Director) bought 1,000 shares at $9.07 ($9K), reported as a purchase (code P). Holdings up <1% to 213,694 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 10, 2026 |
| Mar 31, 2026 | Purchase (code P) | Robert J Michel (CFO) bought 1,000 shares at $9.90 ($10K), reported as a purchase (code P). Holdings up 5% to 21,050 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 31, 2026 |
| Mar 20, 2026 | Other purchase | John Jefferies (Chief Medical Officer) bought 5,941 Daxor Common Stock at $0.0000 ($0), reported as a purchase (code P). Holdings up 34% to 23,557 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 24, 2026 |
| Dec 9, 2025 | Other purchase | Robert J Michel (CFO) bought 3,000 Daxor Common Stock at $0.0000 ($0), reported as a purchase (code P). Holdings up 18% to 20,050 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 11, 2025 |
| Dec 9, 2025 | Other purchase | Jonathan Adam Feldschuh (Chief Scientific Officer and Director) bought 18,000 Daxor Common Stock at $0.0000 ($0), reported as a purchase (code P). Holdings up 50% to 53,908 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 11, 2025 |
| Nov 12, 2025 | Other purchase | John Jefferies (Chief Medical Officer) bought 2,344 Daxor Common Stock at $0.0000 ($0), reported as a purchase (code P). Holdings up 15% to 17,616 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 14, 2025 |
8 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow DXR in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.